Julie Brahmer: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study

Leon, Larry, Kosty, Michael, Jahanzeb, Mohammad, Spigel, David, Wozniak, Antoinette J., Brahmer, Julie, Fish, Susan, Flick, E. Dawn, Hazard, Sebastien J., Lynch, Thomas J.

Journal:

Pharmacoepidemiology and Drug Safety

Year:

2016

Language:

english

File:

PDF, 308 KB

english, 2016

52

Immune Checkpoint Therapy in Non–Small Cell Lung Cancer

Marrone, Kristen A., Brahmer, Julie R.

Journal:

The Cancer Journal

Year:

2016

Language:

english

File:

PDF, 191 KB

english, 2016

53

Symptoms, Supportive Care Needs, and Function in Cancer Patients: How Are They Related?

Claire F. Snyder, Elizabeth Garrett-Mayer, Julie R. Brahmer, Michael A. Carducci, Roberto Pili, Vered Stearns, Antonio C. Wolff, Sydney M. Dy and Albert W. Wu

Journal:

Quality of Life Research

Year:

2008

Language:

english

File:

PDF, 1.40 MB

english, 2008

54

Abstracts: 11th Annual Conference of the International Society for Quality of Life Research (ISOQOL) || # 1128/Using Patient-Reported Questionnaires in Oncology Clinical Practice: Asking the Right Questions

Claire F. Snyder, Sydney M. Dy, Danetta E. Hendricks, Julie R. Brahmer, Antonio C. Wolff and Michael A. Carducci

Journal:

Quality of Life Research

Year:

2004

Language:

english

File:

PDF, 286 KB

english, 2004

55

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30

Claire F. Snyder, Amanda L. Blackford, Julie R. Brahmer, Michael A. Carducci, Roberto Pili, Vered Stearns, Antonio C. Wolff, Sydney M. Dy and Albert W. Wu

Journal:

Quality of Life Research

Year:

2010

Language:

english

File:

PDF, 1.34 MB

english, 2010

56

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227)

Hellmann, Matthew, Ramalingam, Suresh, Reck, Martin, O'Byrne, Ken, Paz-Ares, Luis, Harbison, Christopher T, Bhagavatheeswaran, Prabhu, Nathan, Faith, Brahmer, Julie

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2015

Language:

english

File:

PDF, 255 KB

english, 2015

57

Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-small Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599

Brahmer, Julie R., Dahlberg, Suzanne E., Gray, Robert J., Schiller, Joan H., Perry, Michael C., Sandler, Alan, Johnson, David H.

Journal:

Journal of Thoracic Oncology

Year:

2011

Language:

english

File:

PDF, 100 KB

english, 2011

58

P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis

Borghaei, Hossein, Brahmer, Julie, Horn, Leora, Ready, Neal, Steins, Martin, Felip, Enriqueta, Paz-Ares, Luis, Xx, Xx, Barlesi, Fabrice, Antonia, Scott, Fayette, Jérome, Rizvi, Naiyer, Crino, Lucio, R

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 249 KB

english, 2016

59

Immunotherapy for Lung Cancer: No Longer an Abstract Concept

Marrone, Kristen, Naidoo, Jarushka, Brahmer, Julie

Journal:

Seminars in Respiratory and Critical Care Medicine

Year:

2016

Language:

english

File:

PDF, 193 KB

english, 2016

60

Bevacizumab Maintenance in Patients with Advanced Non–Small-Cell Lung Cancer, Clinical Patterns, and Outcomes in the Eastern Cooperative Oncology Group 4599 Study: Results of An Exploratory Analysis

Lopez-Chavez, Ariel, Young, Todd, Fages, Sophie, Leon, Larry, Schiller, Joan H., Dowlati, Afshin, Brahmer, Julie R., Johnson, David H., Sandler, Alan

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 1.35 MB

english, 2012

61

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

Hellmann, Matthew D, Rizvi, Naiyer A, Goldman, Jonathan W, Gettinger, Scott N, Borghaei, Hossein, Brahmer, Julie R, Ready, Neal E, Gerber, David E, Chow, Laura Q, Juergens, Rosalyn A, Shepherd, France

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 474 KB

english, 2017

62

PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress

Kim, Edward, Dinan, Michaela, Islam, KM Monirul, Fernandes, Ancilla, Schwartzberg, Lee, Croft, Elisabeth, Brahmer, Julie, Mansfield, Aaron, Hyslop, Terry, Burke, Lea, Crawford, Jeffrey

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 101 KB

english, 2016

63

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab

Cappelli, Laura C, Gutierrez, Anna Kristina, Baer, Alan N, Albayda, Jemima, Manno, Rebecca L, Haque, Uzma, Lipson, Evan J, Bleich, Karen B, Shah, Ami A, Naidoo, Jarushka, Brahmer, Julie R, Le, Dung, B

Journal:

Annals of the Rheumatic Diseases

Year:

2017

Language:

english

File:

PDF, 510 KB

english, 2017

64

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.

Journal:

Journal of Thoracic Oncology

Year:

2013

Language:

english

File:

PDF, 324 KB

english, 2013

65

Update in Oncology

Brahmer, Julie R.

Journal:

Annals of Internal Medicine

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

66

ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC

Antonia, Scott J., Gettinger, Scott N., Goldman, Jonathan, Brahmer, Julie, Borghaei, Hossein, Chow, Laura Q., Ready, Neal E., Gerber, David E., Juergens, Rosalyn, Shepherd, Frances, Laurie, Scott A.,

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 227 KB

english, 2016

67

Prognostic Models to Predict Survival in Non–Small-Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 1.64 MB

english, 2012

68

PL04a.01: Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024

Brahmer, Julie R., Rodríguez-Abreu, Delvys, Robinson, Andrew G., Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O’Brien, Mary, Rao, Suman, Hotta, K

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 153 KB

english, 2017

69

P2.03a-010 A Randomized Phase II Study of Platinum-Based Chemotherapy +/- Metformin in Chemotherapy-Naïve Advanced Non-Squamous NSCLC

Marrone, Kristen, Forde, Patrick, Brahmer, Julie, Rosner, Gary, Zhou, Xian, Coleman, Barbara, Ettinger, David

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 210 KB

english, 2017

70

OA20.02 Neoantigen Targeting in NSCLC Patients with Complete Response to Anti-PD-1 Immunotherapy

Smith, Kellie, Anagnostou, Valsamo, Forde, Patrick, Brahmer, Julie, Velculescu, Victor, Pardoll, Drew

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 428 KB

english, 2017

71

OA03.01 First-Line Nivolumab Monotherapy and Nivolumab plus Ipilimumab in Patients with Advanced NSCLC: Long-Term Outcomes from CheckMate 012

Gettinger, Scott, Rizvi, Naiyer, Chow, Laura, Borghaei, Hossein, Brahmer, Julie, Shepherd, Frances, Ready, Neal, Gerber, David, Antonia, Scott, Goldman, Jonathan W., Juergens, Rosalyn, Geese, William,

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 154 KB

english, 2017

72

Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with advanced/metastatic NSCLC: MYSTIC

Rizvi, Naiyer, Barlesi, Fabrice, Brahmer, Julie, Felip, Enriqueta, Forde, Patrick, Garassino, Marina, Goldberg, Sarah, Vansteenkiste, Johan, Jarkowski, Anthony, McIntosh, Stuart, Zhao, Luping, Antonia

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2015

Language:

english

File:

PDF, 374 KB

english, 2015

73

Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?

Juergens, Rosalyn A., Brahmer, Julie R.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2006

Language:

english

File:

PDF, 327 KB

english, 2006

74

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

John P. Crandall,Abdel K. Tahari,Rosalyn A. Juergens,Julie R. Brahmer…

Journal:

EJNMMI Research

Year:

2017

Language:

english

File:

PDF, 1.12 MB

english, 2017

75

Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 3503

Amann, Joseph M., Lee, Ju-Whei, Roder, Heinrich, Brahmer, Julie, Gonzalez, Adriana, Schiller, Joan H., Carbone, David P.

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 296 KB

english, 2010

76

Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade

Kaunitz, Genevieve J., Loss, Manisha, Rizvi, Hira, Ravi, Sowmya, Cuda, Jonathan D., Bleich, Karen B., Esandrio, Jessica, Sander, Inbal, Le, Dung T., Diaz, Luis A., Brahmer, Julie R., Drake, Charles G.

Journal:

American Journal of Surgical Pathology

Year:

2017

Language:

english

File:

PDF, 478 KB

english, 2017

77

PS-3Japan subset of Phase III study KEYNOTE-024: Pembrolizumab for PD-L1 TPS > =50%, treatment-naïve NSCLC

Satouchi, Miyako, Hotta, Katsuyuki, Nosaki, Kaname, Takahashi, Toshiaki, Nakagawa, Kazuhiko, Aoe, Keisuke, Noguchi, Kazuo, Shimamoto, Takashi, Rangwala, Reshma, Brahmer, Julie

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 61 KB

english, 2017

78

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer

Marrone, Kristen A., Zhou, Xian, Forde, Patrick M., Purtell, Michael, Brahmer, Julie R., Hann, Christine L., Kelly, Ronan J., Coleman, Barbara, Gabrielson, Edward, Rosner, Gary L., Ettinger, David S.

Journal:

Year:

2018

Language:

english

File:

PDF, 401 KB

english, 2018

79

Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

Cappelli, Laura C., Brahmer, Julie R., Forde, Patrick M., Le, Dung T., Lipson, Evan J., Naidoo, Jarushka, Zheng, Lei, Bingham, Clifton O., Shah, Ami A.

Journal:

Seminars in Arthritis and Rheumatism

Year:

2018

Language:

english

File:

PDF, 331 KB

english, 2018

80

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Brahmer, Julie R., Govindan, Ramaswamy, Anders, Robert A., Antonia, Scott J., Sagorsky, Sarah, Davies, Marianne J., Dubinett, Steven M., Ferris, Andrea, Gandhi, Leena, Garon, Edward B., Hellmann, Matt

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2018

Language:

english

File:

PDF, 912 KB

english, 2018

81

Nivolumab Plus Erlotinib in Patients With EGFR -Mutant Advanced NSCLC

Gettinger, Scott, Hellmann, Matthew D., Chow, Laura Q.M., Borghaei, Hossein, Antonia, Scott, Brahmer, Julie R., Goldman, Jonathan W., Gerber, David E., Juergens, Rosalyn A., Shepherd, Frances A., Laur

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 437 KB

english, 2018

82

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer

Wills, Beatriz, Brahmer, Julie R., Naidoo, Jarushka

Journal:

Current Treatment Options in Oncology

Year:

2018

Language:

english

File:

PDF, 1.07 MB

english, 2018

83

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Taunk, Neil K., Rimner, Andreas, Culligan, Melissa, Friedberg, Joseph S., Brahmer, Julie, Chaft, Jamie

Journal:

Translational Lung Cancer Research

Year:

2007

Language:

english

File:

PDF, 190 KB

english, 2007

84

PD3-3-5: Outcomes for elderly advanced stage non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (B) in combination with carboplatin (C) and paclitaxel (P): Analysis of Eastern Cooperative Oncology Group (ECOG) 4599 study

Ramalingam, Suresh S., Dahlberg, Suzanne E., Langer, Corey J., Gray, Robert, Belani, Chandra P., Brahmer, Julie R., Sandler, Alan, Schiller, Joan H., Johnson, David H.

Journal:

Journal of Thoracic Oncology

Year:

2007

Language:

english

File:

PDF, 173 KB

english, 2007

85

Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer

Phallen, Jillian, Leal, Alessandro, Woodward, Brian D, Forde, Patrick M, Naidoo, Jarushka, Marrone, Kristen A, Brahmer, Julie R., Fiksel, Jacob, Medina, Jamie E, Cristiano, Stephen, Palsgrove, Doreen

Journal:

Cancer Research

Year:

2018

Language:

english

File:

PDF, 3.93 MB

english, 2018

86

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

Bott, Matthew J., Yang, Stephen C., Park, Bernard J., Adusumilli, Prasad S., Rusch, Valerie W., Isbell, James M., Downey, Robert J., Brahmer, Julie R., Battafarano, Richard, Bush, Errol, Chaft, Jamie,

Journal:

The Journal of Thoracic and Cardiovascular Surgery

Year:

2018

Language:

english

File:

PDF, 513 KB

english, 2018

87

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Brahmer, Julie R., Lacchetti, Christina, Schneider, Bryan J., Atkins, Michael B., Brassil, Kelly J., Caterino, Jeffrey M., Chau, Ian, Ernstoff, Marc S., Gardner, Jennifer M., Ginex, Pamela, Hallmeyer,

Journal:

Journal of Clinical Oncology

Year:

2018

File:

PDF, 1.29 MB

2018

88

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients

Smith, Thomas J., Hanna, Nasser, Johnson, David, Baker, Sherman, Biermann, William A., Brahmer, Julie, Ellis, Peter M., Giaccone, Giuseppe, Hesketh, Paul J., Jaiyesimi, Ishmael, Leighl, Natasha B., Ri

Journal:

Journal of Oncology Practice

Year:

2017

File:

PDF, 577 KB

2017

89

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary

Brahmer, Julie R., Lacchetti, Christina, Thompson, John A.

Journal:

Journal of Oncology Practice

Year:

2018

File:

PDF, 534 KB

2018

90

EGFR -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Marcoux, Nicolas, Gettinger, Scott N., O’Kane, Grainne, Arbour, Kathryn C., Neal, Joel W., Husain, Hatim, Evans, Tracey L., Brahmer, Julie R., Muzikansky, Alona, Bonomi, Philip D., del Prete, Salvator

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 1.15 MB

english, 2019

91

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Brahmer, Julie R., Lacchetti, Christina, Schneider, Bryan J., Atkins, Michael B., Brassil, Kelly J., Caterino, Jeffrey M., Chau, Ian, Ernstoff, Marc S., Gardner, Jennifer M., Ginex, Pamela, Hallmeyer,

Journal:

Journal of Clinical Oncology

Year:

2018

Language:

english

File:

PDF, 1.29 MB

english, 2018

92

A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer

Parikh, Anish B., Marrone, Kristen A., Becker, Daniel J., Brahmer, Julie R., Ettinger, David S., Levy, Benjamin P.

Journal:

Cancer Treatment and Research Communications

Year:

2019

Language:

english

File:

PDF, 1.05 MB

english, 2019

93

Safety and Efficacy of Pembrolizumab Monotherapy in Elderly Patients With PD-L1–Positive Advanced Non–Small-Cell Lung Cancer: Pooled Analysis From the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 Studies

Nosaki, Kaname, Saka, Hideo, Hosomi, Yukio, Baas, Paul, de Castro, Gilberto, Reck, Martin, Wu, Yi-Long, Brahmer, Julie R., Felip, Enriqueta, Sawada, Takeshi, Noguchi, Kazuo, Han, Shi Rong, Piperdi, Bi

Journal:

Year:

2019

Language:

english

File:

PDF, 437 KB

english, 2019

94

Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature

Zhang, Yuan, Zhang, Sean X., Trivedi, Julie, Toll, Adam D., Brahmer, Julie, Hales, Russell, Bonerigo, Sarah, Zeng, Mingying, Li, Huiping, Yung, Rex C.

Journal:

BMC Infectious Diseases

Year:

2019

Language:

english

File:

PDF, 1.81 MB

english, 2019

95

Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC

Antonia, Scott J., Balmanoukian, Ani, Brahmer, Julie, Ou, Sai-Hong I., Hellmann, Matthew D., Kim, Sang-We, Ahn, Myung-Ju, Kim, Dong-Wan, Gutierrez, Martin, Liu, Stephen V., Schöffski, Patrick, Jäger,

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 1.54 MB

english, 2019

96

C-102 Early stage non small cell lung cancer

Journal:

JAIDS Journal of Acquired Immune Deficiency Syndromes

Year:

2019

File:

PDF, 3.28 MB

2019

97

Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

Braaten, Tawnie J, Brahmer, Julie R, Forde, Patrick M, Le, Dung, Lipson, Evan J, Naidoo, Jarushka, Schollenberger, Megan, Zheng, Lei, Bingham, Clifton O, Shah, Ami A, Cappelli, Laura C

Journal:

Annals of the Rheumatic Diseases

Year:

2019

File:

PDF, 433 KB

2019

98

Therapy for Stage IV NonâSmall-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Hanna, Nasser H., Schneider, Bryan J., Temin, Sarah, Baker, Sherman, Brahmer, Julie, Ellis, Peter M., Gaspar, Laurie E., Haddad, Rami Y., Hesketh, Paul J., Jain, Dharamvir, Jaiyesimi, Ishmael, Johnson

Journal:

Journal of Clinical Oncology

Year:

2020

Language:

english

File:

PDF, 672 KB

english, 2020

99

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Ascierto, Paolo Antonio, Fox, Bernard A, Urba, Walter J, Anderson, Ana Carrizosa, Atkins, Michael B, Borden, Ernest C, Brahmer, Julie R, Butterfield, Lisa H, Cesano, Alessandra, Chen, Daniel S, de Gru

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2020

File:

PDF, 406 KB

2020

100

Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely

Calles, Antonio, Riess, Jonathan W., Brahmer, Julie R.

Journal:

American Society of Clinical Oncology Educational Book

Year:

2020

File:

PDF, 543 KB

2020